Virpax Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Berwyn, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Virpax Pharmaceuticals, Inc. has filed 278 SEC EDGAR filings since 05 Apr 2018

SEC filing history

Showing 126-150 of 278 matching filings.

Per page
25
Current page
6
3

3 filing

Filing date
03 Oct 2023
Reporting date
27 Sep 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
05 Sep 2023
Reporting date
01 Sep 2023
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
16 Aug 2023
Reporting date
15 Aug 2023
Next action
Verify source filing
4/A

4/A filing

Filing date
16 Aug 2023
Reporting date
20 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
14 Aug 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
14 Aug 2023
Reporting date
14 Aug 2023
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
26 Jul 2023
Reporting date
24 Jul 2023
Next action
Verify source filing
DEFA14A File 001-40064

DEFINITIVE ADDITIONAL MATERIALS

Filing date
22 Jun 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Jun 2023
Reporting date
20 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
21 Jun 2023
Reporting date
20 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
21 Jun 2023
Reporting date
18 Jun 2023
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
07 Jun 2023
Reporting date
07 Jun 2023
Next action
Verify source filing
ARS File 001-40064

ANNUAL REPORT

Filing date
07 Jun 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40064

PROXY STATEMENT

Filing date
07 Jun 2023
Reporting date
24 Jul 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
12 May 2023
Reporting date
31 Mar 2023
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
12 May 2023
Reporting date
12 May 2023
Next action
Verify source filing
4

4 filing

Filing date
26 Apr 2023
Reporting date
24 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
14 Apr 2023
Reporting date
10 Apr 2023
Next action
Verify source filing
4

4 filing

Filing date
28 Mar 2023
Reporting date
24 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
28 Mar 2023
Reporting date
24 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-40064

ANNUAL REPORT

Filing date
22 Mar 2023
Reporting date
31 Dec 2022
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
22 Mar 2023
Reporting date
22 Mar 2023
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
13 Mar 2023
Reporting date
13 Mar 2023
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
17 Feb 2023
Reporting date
17 Feb 2023
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .